Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 7/20 | 0.35 |
| ▸ | RORC | P51449 | 6/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.33 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.33 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.33 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21758704 | 0.95 | SLC22A12 (0.38) | SLC22A12CYP11B2CYP11B1CYP19A1CSNK1D | |
| SCHEMBL21758174 | 0.94 | RORC (0.36) | SLC22A12RORCCYP11B2CYP11B1CYP19A1 | |
| SCHEMBL21758486 | 0.91 | CYP3A4 (0.37) | SLC22A12CYP19A1 | |
| SCHEMBL21758474 | 0.90 | CHUK (0.38) | SLC22A12RORCCYP11B2CYP11B1CYP19A1 | |
| SCHEMBL21396782 | 0.89 | CYP11B2 (0.38) | SLC22A12CYP11B2CYP11B1CYP19A1PTGER4 | |
| SCHEMBL21758335 | 0.89 | RORC (0.35) | RORCCYP11B2CYP11B1CYP19A1PTGER4 | |
| SCHEMBL21758178 | 0.88 | CYP11B2 (0.38) | SLC22A12CYP11B2CYP11B1CYP19A1CSNK1D | |
| SCHEMBL21758159 | 0.88 | CYP11B2 (0.37) | SLC22A12RORCCYP11B2CYP11B1PTGER4 | |
| SCHEMBL23255429 | 0.87 | CYP3A4 (0.37) | SLC22A12CYP11B2CYP11B1PTGER4 | |
| SCHEMBL21758709 | 0.86 | CYP19A1 (0.34) | SLC22A12RORCCYP11B2CYP11B1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OXER1, OR10J3, OXGR1 | SLC22A12 2205/4885RORC 254/4885CYP11B2 1243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.